Oral labetalol versus oral nifedipine for the management of postpartum hypertension a randomized control trial

Jahanara Ainuddin, Fariha Javed, Sarah Kazi, Jahanara Ainuddin, Fariha Javed, Sarah Kazi

Abstract

Objective: To compare the efficacy of oral Labetalol versus oral Nifedipine for the treatment of postpartum hypertension.

Methods: A prospective randomized controlled trial with parallel assignment was conducted in the department of Obstetrics and Gynecology, Dow University of Health Sciences Karachi, Pakistan, 124 patients with post partum hypertension were selected and randomized into two groups with 62 patients receiving Labetalol and 62 receiving long acting nifedipine. Initial blood pressures were recorded, and the respective drug was administered. Dose adjustments were performed in the initial 24 hours. The outcome was measured in the form of drug efficacy by lowering of systolic blood pressure less than 140mm of Hg and diastolic less than 90mm of Hg up to 48 hours after starting treatment. Data was entered and analyzed through SPSS version 20.

Results: Our study randomized 62 women to oral labetalol and 62 women to oral long acting nifedipine. The time required to achieve blood pressure control was 35.6±2.8 hours in labetalol group and 30.4±1.9 hours in nifedipine group (p=0.04).length of hospital stay, need of additional antihypertensive medications were same in both groups. Minor side effects were observed more in nifedipine group.

Conclusion: We conclude that both oral labetalol and oral long acting nifedipine are effective and well tolerated interventions for the management of post-partum hypertension. However we found Nifidipine more effective in the management of postpartum hypertension.

Keywords: Labetalol; Nifedipine; Postpartum hypertension.

Conflict of interest statement

Conflicts of interest and financial disclosures: None.

Figures

Fig.1
Fig.1
Flow Diagram.

References

    1. Bramhan K, Piercy N, Brown JM, Chappell LC. Post-partum management of hypertension. BMJ. 2013;346:30–34. doi:10.1136/bmj.f894.
    1. Podymow T, August P. Post-partum course of gestational hypertension and pre-eclampsia. Hypertens Pregnancy. 2010;29(3):294–300. doi:10.3109/10641950902777747.
    1. Goel A, Maski MR, Bajrachrya S, Wenger JB, Zhang D, Salahuddin S, et al. Epidemiology and mechanism of De NOVO and persistent hypertension in the post-partum period. Circulation. 2015;132(18):1726–1733. doi:10.1161/CIRCULATIONAHA.115.015721.
    1. National Institute of Health Care Excellence NICE. Clinical guidelines 107:Hypertension in pregnancy:The management of hypertensive disorders during pregnancy. 2011. [Accessed in June 2019]. Available at: .
    1. ACOG Task force on hypertension in pregnancy. Hypertension in pregnancy. Am Coll Obstet Gynecol. 2013. [Accessed in June 2019]. Available at: .
    1. Lewis G The confidential Enquiry into maternal and child Health (CEMACH) Saving mothers Lives, reviewing Maternal Deaths to make Motherhood safer 2003-2005. The seventh report on confidential requires into maternal deaths in United Kingdom London: CEMACH. 2017. [Accessed in June 2019]. Available at: .
    1. Mage L, Von Dadleszen P. Prevention and treatment of Post-partum hypertension. Cochrane Database Syst Rev. 2013;4:CD004351. doi:10.1002/14651858.CD004351.pub3.
    1. Medicines and Health Care products regulatory agency ACE inhibitors and angiotensin II receptor antagonists: recommendations on use during breast feeding. 2009. .
    1. ACOG committee opinion, 767, Emergent therapy for acute onset, severe hypertension during pregnancy and the post-partum period. Obstet Gynecol. 2019;133(2):e174–e180. doi:10.1097/AOG.0000000000003075.
    1. Raheem IA, Saaid R, Omar SZ, Tan PC. Oral nifedipine versus intravenous labetolol for acute blood pressure control in hypertensive emergencies of pregnancy:a randomized trial. BJOG. 2012;119(1):78–85. doi:10.111/j.1471-0528.2011.03151.
    1. Griffs KR, Jr, Martin JN, Jr, Palmer SM, Martin RW, Morrison JC. Utilization of hydralazine of alpha-methyldopa for the management of early puerperal hypertension. Am J Perinatal. 1989;6(4):437–441. doi:10.1055/s-2007-999634.
    1. Gracia PVD, Ruiz E, Lopez JC, de Jaramillo IA, Vega-Maleck JC, Pinzon J. Management of severe hypertension in the post-partum with intravenous hydralazine or labetalol;a randomized clinical trial. Hypertens Pregnancy. 2007;26(2):163–167. doi:10.1080/10641950701204430.
    1. Vermillion ST, Scardo JA, Naoman RB, Chauhan SP. A randomminzed double blind trial of oral nifedipine and intravenous labetolol in hypertensive emergencies of pregnancy. AJOG. 1999;181(4):858–861. doi:10.1016/s0002-9378(99)70314-5.
    1. Svichenko EP, Kupen Hinskala E, Zanozdra NZ, Bezodarak LV, Radchenko W. A comparative analysis of antihypertensive actively of calcium antagonists and adrenoblockers in long term treatment. KLIN Med (MOSK) 1992;70(11-12):34–37.
    1. Beardmoor KS, Morris JM, Gallery EDM. Excretion of antihypertensive medication into human breast milk;a systematic review. Hypertens Pregnancy. 2002;21(1):85–95. doi:10.1081/PRG-120002912.
    1. Hasnai S, Khan M, Saleem A, Waqar M. Prevalence of asthama allergic shinitis among school children of Karachi, Pakistan 2007. J Asthma. 2009;46(1):86–90. doi:10.1080/02770900802513023.
    1. Firoz T, Magee LA, MacDonell K, Payne BA, Gordon R, Vidler M, et al. Oral antihypertensive therapy for severe hypertension in pregnancy and post-partum:a systematic review. BJOG. 2014;121(10):1210–1218. discussion 1220. doi:10.1111/1471-0528.12734.
    1. Raheem A, Saaid R, Omar S, Tan PC. Oral nifedipine versus intravenous labetolol for acute blood pressure control in hypertensive emergencies of pregnancy:a randomized trial. BJOG. 2012;119(1):78–85. doi:10.1111/j.1471-0528.2011.03151.x.
    1. Cairns AE, Pealing L, Duffy JMN, Roberts N, Tucker KL, Leason P, et al. Post-partum management of hypertensive disorders of pregnancy:a systematic review. BMJS Open. 2017;7(11):e18696. doi:10/bmj open-2017-018696.
    1. Vermillion ST, Scardo JA, Newmann RB, Chauhan SP. A randomized double blind trial of oral nifedipine and intravenous labetolol in hypertensive emergencies of pregnancy. Am J Obstet Gynaecol. 1999;181(4):858–861. doi:10.1016/s0002-9378(99)70314-5.
    1. Veena P, Perivela L, Raghavan SS. Furosemide in Post-partum management of severe pre-eclampsia:a randomized controlled trial. Hyperten Pregnancy. 2017;36(1):84–89. doi:10.1080/10641955.2016.1239735.
    1. Shumard K, Yoon J, Huang C, Nitsche JF. Peripartum antihypertensive choice effects time to blood pressure control in treating hypertensive disorders of pregnancy. Am J Obstet Gynaecol. 2016;214(1):S378. doi:10.1016/j.ajog.2015.10.766.
    1. Sharma KJ, Greene N, Kilpatrick SJ. Oral Labetolol compared to oral nifedipine for post-partum hypertension. A randomized controlled trial. Hyperten Pregnancy. 2017;36(1):44–47. doi:10.1080/10641955.2016.1231317.
    1. Beatty CA, Dangel A. Timely discharge:oral nifedipine is superior to labetolol for post-partum BP control in patients with preeclampsia. Obstet Gynaecol. 2018;131:201S–202S. doi:10.1097/01.AOG.0000533278.70668.81.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever